George W. Lloyd - Aug 6, 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP, Investments & CLO
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Stock symbol
RPRX
Transactions as of
Aug 6, 2025
Transactions value $
$0
Form type
4
Date filed
8/8/2025, 04:56 PM
Previous filing
May 20, 2025
Next filing
Nov 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lloyd George W. EVP, Investments & CLO C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd 2025-08-08 0001814899

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $0 +3.7K +7.6% $0.00 52.3K Aug 6, 2025 By GWL 2023 G HoldCo LLC F1
holding RPRX Class A Ordinary Shares 3K Aug 6, 2025 Direct
holding RPRX Class A Ordinary Shares 274K Aug 6, 2025 By IRA
holding RPRX Class A Ordinary Shares 496K Aug 6, 2025 By GWL 2013 NG, LLC
holding RPRX Class A Ordinary Shares 220K Aug 6, 2025 By GWL 2014 G, LLC
holding RPRX Class A Ordinary Shares 52K Aug 6, 2025 By GWL 2020 G, LLC
holding RPRX Class A Ordinary Shares 28K Aug 6, 2025 By GWL 2021 G, LLC
holding RPRX Class A Ordinary Shares 4.01K Aug 6, 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPRX LP interests in RPI US Partners 2019, LP Gift $0 -8.5K -100% $0.00 0 Aug 8, 2025 Class A Ordinary Shares 85K Direct F2, F3
holding RPRX LP interests in RPI US Partners 2019, LP 58.2K Aug 6, 2025 Class A Ordinary Shares 582K $0.00 By GWL 2013 NG, LLC F3
holding RPRX LP interests in RPI US Partners 2019, LP 292K Aug 6, 2025 Class A Ordinary Shares 2.92M $0.00 By GWL 2014 G, LLC F3
holding RPRX LP interests in RPI US Partners 2019, LP 273K Aug 6, 2025 Class A Ordinary Shares 2.73M $0.00 By GWL 2020 G, LLC F3
holding RPRX LP interests in RPI US Partners 2019, LP 130K Aug 6, 2025 Class A Ordinary Shares 1.3M $0.00 By GWL 2021 G LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
F2 No limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP ("RPI US LP Interest") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with an exchange.
F3 Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.